New Evolutionary Synthesis Tool for Modelling Young Star Clusters in Merging Galaxies

P. Anders,R. Grijs,Uta Fritze - v. Alvensleben Universitaets-Sternwarte Goettingen,H Germany,I. O. Astronomy,Cambridge,UK.

DOI: https://doi.org/10.1007/10857603_40

2002-10-14

Abstract:

What problem does this paper attempt to address?

Isolated Idiopathic Transient Hyperphosphatasemia in an Adult Patient after Renal Transplantation: a Case Report.

Hyeon Jeong Lee,Jong Woo Seo,Dong Won Lee,Hyun-Jung Kim,Dong Jun Park,Se-Ho Chang

DOI: https://doi.org/10.5414/cn107024

2012-01-01

Clinical Nephrology

Abstract:Transient hyperphosphatasemia (TH) is characterized by the isolated elevation of serum alkaline phosphatase (ALP) in children. There is no evidence of liver or bone disease and the ALP levels return to normal within 4 months. Few adult cases have been reported. Here, we report the case of TH in a 54-year-old woman, who for 4 years after receiving a renal transplant, was regularly followed up at a renal outpatient clinic. Her underlying disease was chronic glomerulonephritis, for which she was taking immunosuppressive drugs (cyclosporine and mycophenolate mofetil). Routine laboratory analyses revealed that her ALP level had risen to 909 IU/l, which is a seven-fold increase relative to the upper normal limit (35 - 130 IU/l). The levels of intact parathyroid hormone; the tumor markers CEA, α-FP, CA 19-9, and CA 125; and other serum parameters were normal. The patient lacked symptoms, relevant clinical signs, and evidence of acute infection or acute chronic gastrointestinal disease. Lymph node enlargement and malignancy were not detected on a physical examination and ultrasonographic analysis of the abdomen, respectively. A bone scan showed no evidence of bone pathology. ALP isoenzyme analysis by electrophoresis showed patterns similar to those seen in TH of infancy and childhood. The ALP levels of the patient returned spontaneously to 126 IU/l 5 months after diagnosis. While isolated hyperphosphatasemia in renal transplantation patients may be a benign condition, we recommend that such cases be differentially diagnosed from other diseases that can trigger hyperphosphatasemia, including malignancy, infection, bone and liver diseases.
Dynamics in the mixed microbial concourse.

E. Wintermute,P. Silver

DOI: https://doi.org/10.1101/gad.1985210

IF: 12.89

2010-12-01

Genes & Development

Abstract:Isolated, clonal populations of cells are rarely found in nature. The emergent properties of microbial consortia present a challenge for the systems approach to biology, as chances for competition, communication, or collaboration multiply with the number of interacting agents. This review focuses on recent work on intercourse within biofilms, among quorum-sensing populations, and between cross-feeding metabolic cooperators. New tools from synthetic biology allow microbial interactions to be designed and tightly controlled, creating valuable model systems. We address both natural and synthetic partnerships, with an emphasis on how system behaviors derive from the properties of their components. Essential features of microbial biology arose in the context of a very mixed culture and cannot be understood without unscrambling it.
[Aseptic osseous necrosis after renal transplantation]

A Muolo,E Galvani,A Marabini,G Ancona,P G Giorgetti,G F Zampieri,M Longo,S Bandini,P Confortini

1980-05-31

Abstract:Of 165 renal Transplantated patients, 12 developed aseptic bone necrosis in the femoral head (6 patients), in the femoral condyle (5 patients), in the astragalus (1 patient). The onset of symptoms was 6 to 23 months after transplantation. 99mTc-O4-MDP bone scintigraphy and radiological examination associated with clinical signs confirmed the diagnosis. Unresolved hyperparathyroidism, phosforus depletion, ponderal increase, total i.v. prednisolone-boluses and trauma represented conditions which might predispose to the development of lesion. 8 patients were managed with conservative treatment. 4 patients required a total of 8 operations: head replacement arthroplasty and articular cartilage reimplant in two patients with disease involving femoral head; articular cartilage reimplant and condyle replacement arthroplasty in two patients with disease involving femoral condyle.
Clinical Analysis of Persistent Hypercalcemia with Osteoporosis Caused by Tertiary Hyperparathyroidism after Kidney Transplantation

Wang Suya,Wu Jianyong,Peng Wenhan,Wang Rending,Huang Hongfeng,Chen Jianghua

DOI: https://doi.org/10.3760/cma.j.issn.0254-1785.2019.02.007

2019-01-01

Abstract:Objective To explore the clinical characteristics of tertiary hyperparathyroidism (THPT) after renal transplantation .Methods The levels of bone mineral density (BMD) , serum calcium , phosphates , alkaline phosphatase (ALP) and intact parathyroid hormone (iPTH ) were retrospectively analyzed in 36 RTx recipients with persistent hypercalcemia and stable kidney function (eGFR 76 .71 ± 17 .44) ml/min/1 .73 m2 .Results Among them ,serum total calcium level increased (2 .97 ± 0 .20 ) mmol/L for 6 to 170 months ,blood phosphorus decreased (0 .59 ± 0 .19 ) mmol/L , serum alkaline phosphatase (ALP) increased to (295 .73 ± 194 .22)U/L and T-score of BMD decreased (T - 2 .78 ± 0 .84 in lumbar vertebrae and T - 2 .09 ± 0 .66 in hip joint) .And 11 /36 (30 .6％ ) cases had a complication of extraosseous calcification .Parathyroid hyperplasia was detected in 17 /36 cases (47 .2％ ) .iPTH was significantly higher at pre-operation and 1 week post-operation than that in control group (n= 45) (859 .50 ± 495 .44 vs 345 .56 ± 216 .55 pg/ml) , P = 0 .001 ,(759 .25 ± 907 .07 vs 197 .45 ± 249 .31 pg/ml) , P= 0 .001 .The value of iPTH at the last follow-up (198 .26 ± 155 .22) pg/ml was still higher than normal reference value (15 .0 - 65 .0 pg/ml) . Multivariate stepwise regression analysis showed the last iPTH was correlated with preoperative iPTH ,serum calcium and postoperative serum phosphor ,ALP and 25OHD3 (P= 0 .024 , P= 0 .002 , P = 0 .001 , P = 0 .037 , P = 0 .026 ) .Conclusions Renal recipients had a higher levels iPTH with persistent hypercalcemia , hypophosphatemia , osteoporosis and extraosseous calcification showing the features of tertiary hyperparathyroidism .
The effect of probucol on HDL-mediated sterol translocation and efflux from cells.

S. Zambon,R. Brazg,M. Aviram,J. Oram,E. Bierman

DOI: https://doi.org/10.1016/0021-9150(92)90187-L

IF: 5.3

1992-05-01

Atherosclerosis

Abstract:
How to increase the population of a Phlebotomus perniciosus (Diptera: Psychodidae) colony: a new method.

P. M. Alarcón-Elbal,Begoña García Montoliu,Rocío Pinal,S. Delacour-Estrella,I. Ruíz-Arrondo,M. A. Peribáñez,I. de Blas,R. Molina,J. Castillo,Lorenzo Diéguez-Fernández,J. Lucientes

DOI: https://doi.org/10.1590/S0074-02762011000600013

2011-09-01

Memórias do Instituto Oswaldo Cruz

Abstract:The sandfly Phlebotomus perniciosus is the most widespread vector of Leishmania infantum in Spain. Laboratory colonisation represents the most feasible source of information on the biology of these insects, but in conducting any study, the density of individuals in the colony may drop to such an extent that it is sometimes difficult to recover the initial population levels. A new technique was tested for the recovery of sandfly eggs in three different colonies; the recovery rate was studied by comparing the standard method of mass rearing with this new method of colony management. The results demonstrate a mean increase of 18.4% in adult production, a growth in colony productivity that justifies the inclusion of this process in the routine maintenance of any colony of sandflies.
Bone disease after renal transplantation

James G Heaf

DOI: https://doi.org/10.1097/01.TP.0000043926.74349.6D

2003-02-15

Transplantation

Abstract:Bone disease is common after renal transplantation. The main syndromes are bone loss with a consequent fracture rate of 3% per year, osteonecrosis of the hip, and bone pain. The causes of disease include preexisting uremic osteodystrophy (hyperparathyroidism, aluminum osteomalacia, beta2-associated amyloidosis, and diabetic osteopathy), postoperative glucocorticoid therapy, poor renal function, and ongoing hyperparathyroidism, as the result of either autonomous transformation of the parathyroid gland or ongoing physiologic stimuli. Cyclosporine A treatment, hyperphosphaturia, and a pathogenic vitamin D allele have also been implicated. Bone loss is particularly pronounced during the first year after operation, amounting to up to 9% of bone mass. The clinical and biochemical picture is consistent with a high turnover bone disease, but histomorphometric studies do not completely support this. Principal prophylactic options include preoperative osteodystrophy prophylaxis; postoperative calcium, vitamin D, or calcitriol therapy; estrogen therapy for postmenopausal women; and parathyroidectomy for medically intractable hyperparathyroidism. Recently, prophylactic biphosphonate treatment has shown promise, but the exact indications for treatment remain to be determined.
[Disturbances of the calcium-phosphorus metabolism and skeletal diseases following kidney transplantation]

W Flury,B Haldimann

1981-01-03

Abstract:53 patients were followed up for an average of 3 years after renal transplantation for evaluation of disturbances in calcium-phosphorus metabolism and skeletal diseases. Postoperative hypercalcemia and hypophosphatemia can be related to persistence of hyperparathyroidism when kidney function is restored. Hypercalcemia was observed in 43% of the patients and lasted less than one year in 80% of cases. Transient hypophosphatemia was present in 15%. These abnormalities did not cause clinical symptoms or deterioration of renal function. However, the skeletal diseases are more impressive and in the first place osteopenia. Bone densitometry revealed decreased bone mineral content in two thirds of the females and one fifth of the males. In females the bone density decreased 3.3% during an average observation period of 7 months, but remained constant in males. Renal osteodystrophy is the main cause of the initial osteopenia. The absence of remineralization or the progression of bone losses is related to the initial persistence of hyperparathyroidism and to corticosteroid treatment. According, 12.5% of the patients presented pathological fractures (spine, hip). In 3 patients (5.7%) with reduced transplant function, osteomalacia without hypophosphatemia was observed. 4 patients (7.5%) had osteonecrosis of the femoral head. There was little progression and surgery was not necessary.
Musculoskeletal complications after renal transplantation: pathogenesis and treatment

B A Julian,L D Quarles,K M Niemann

DOI: https://doi.org/10.1016/s0272-6386(12)70118-x

Abstract:Renal transplantation is associated with several abnormalities of function and structure of the musculoskeletal system. Some of these skeletal problems result from incomplete resolution of abnormalities of bone and mineral metabolism present at the time of transplantation. In this regard, persistent hyperparathyroidism, diabetes mellitus type 1, and accumulation of beta 2-microglobulin may lead to residual skeletal effects despite excellent function of the allograft. Persistent hyperparathyroidism may accelerate bone loss and increase the risk for osteonecrosis, as well as cause hypercalcemia and hypophosphatemia; some patients with severe hyperparathyroidism require parathyroid surgery. Osteonecrosis is the most debilitating skeletal complication after transplantation and frequently requires surgical therapy. Although osteomalacia associated with aluminum overload generally resolves after transplantation, bone complications due to dialysis amyloidosis and diabetes mellitus type 1 often fail to improve. Alternatively, skeletal abnormalities can be acquired after transplantation. Most of the new derangements of bone and mineral metabolism are due to the immunosuppressive medications. Toxic effects of glucocorticoids on bone contribute to the pathogenesis of osteonecrosis, increase the risk for fractures by decreasing cancellous bone mass and synthesis of bone matrix, and dampen the linear growth response in pediatric recipients. Whether cyclosporine independently causes appreciable toxic effects on bone metabolism is not yet clear, but use of this drug increases the prevalence of gout and dental problems. Osteonecrosis, osteopenia, and short stature remain important skeletal complications in recipients of renal allografts. Therapeutic efforts should be directed toward alleviating pretransplant bone disease and attenuating bone loss after transplantation.
The decreased incidence of aseptic necrosis in renal transplant recipients--a case control study

P S Parfrey,D Farge,N A Parfrey,J A Hanley,R D Guttman

DOI: https://doi.org/10.1097/00007890-198602000-00010

Transplantation

Abstract:Before 1971 the incidence of aseptic necrosis in renal transplant recipients was 29%, and after 1971 it was 5%. To investigate the reasons for this decreased incidence and to elucidate the causes of aseptic necrosis we studied all 26 transplant patients with aseptic necrosis and 42 controls matched for year of transplantation, age, and sex. Development of aseptic necrosis was not related to duration of dialysis before transplant, severity of uremia at the time the patient started dialysis, adequacy of dialysis before transplantation, transplant dysfunction at the time aseptic necrosis was diagnosed, hyperparathyroidism before or after transplantation, lack of Vitamin D supplementation after transplantation, or fatty infiltration of liver. Total steroid dose 1 month after transplantation was actually lower in aseptic necrosis compared with the control group (2.47 +/- 0.3 g vs. 3.6 +/- 0.3 g SEM g) and was similar after 4 months (6.72 +/- 0.55 g vs. 7.14 +/- 0.6 g), as were total numbers of i.v. doses of methylprednisolone or hydrocortisone. However, blood urea nitrogen (BUN) during the dialysis period was significantly higher in the aseptic necrosis group. Of the aseptic necrosis group, 27% had a previous transplant compared with 5% of controls. Half the aseptic necrosis group (5/10) had parenchymal iron on liver biopsy one year after transplant compared with 15% (2/13) of those without aseptic necrosis. Patients transplanted before 1971 (with and without aseptic necrosis) received significantly more i.v. hydrocortisone and less i.v. methylprednisolone, had higher BUN levels at the time of starting dialysis, and had lower serum calcium and higher serum phosphate at transplantation compared with patients transplanted in or after 1971. The incidence of aseptic necrosis following transplantation has decreased during the past 13 years for reasons that are unclear. Risk factors for aseptic necrosis may include previous transplantation, severe iron overload that may lead to marrow fibrosis and osteopenia, and increased protein catabolism/turnover during dialysis.
Associated Factors of Osteoporosis and Vascular Calcification in Patients Awaiting Kidney Transplantation.

Junhao Lv,Wenqin Xie,Suya Wang,Yilin Zhu,Yaomin Wang,Ping Zhang,Jianghua Chen

DOI: https://doi.org/10.1007/s11255-023-03606-0

IF: 2.2662

2023-01-01

International Urology and Nephrology

Abstract:Introduction Pretransplant osteoporosis and vascular calcification probably increase the risk of fractures and cardiovascular events after kidney transplantation. In the present study, we investigated the related risk factors of osteoporosis and vascular calcification among end-stage renal disease (ESRD) patients awaiting kidney transplantation. Methods A total of 221 ESRD patients (age, 43.4 ± 14.3 years; 125 males and 96 females; median dialysis duration, 61.0 m) awaiting kidney transplantation were enrolled in this cross-sectional study. Serum levels of bone turnover markers and intact parathyroid hormone (iPTH) were analyzed from fasting morning blood samples. Dual-energy X-ray absorptiometry was used to measure bone mineral density (BMD). Vascular calcification was evaluated by lateral abdominal radiography and plain radiographic films of the pelvis and hands. Results The osteoporosis prevalence was 27.6% in this cohort of kidney transplantation candidates, and the prevalence of vascular calcification was 51.1%. The related factors for osteoporosis and vascular calcification were similar and included older age, longer dialysis duration, parathyroid hyperplasia, and higher levels of iPTH and bone turnover markers. In the multivariable regression model, age and iPTH were independent risk predictors of both vascular calcification and osteoporosis. There were strong, positive correlations between iPTH and all bone turnover markers. The moderate and severe hyperparathyroidism (iPTH 600–1499 pg/ml and iPTH 1500 pg/ml) were related to reduced serum albumin and hemoglobin levels. Conclusion The involvement of high iPTH levels in vascular calcification, osteoporosis, and malnutrition indicated the need of treating hyperparathyroidism early in patients awaiting kidney transplantation. Prospective studies are needed to further examine the utility of bone turnover markers.
[Therapy recommendations for the use of intravenously applicable immunoglobulins].

J. Marschner,N. Rietbrock

1996-03-15

Medizinische Klinik

Abstract:
Disparities in physician care: experiences and perceptions of a multi-ethnic America.

R. Blendon,T. Buhr,E. Cassidy,D. Pérez,T. Sussman,J. Benson,M. Herrmann

DOI: https://doi.org/10.1377/hlthaff.27.2.507

2008-03-01

Health Affairs

Abstract:This 2007 Harvard School of Public Health/Robert Wood Johnson Foundation survey of 4,334 randomly selected U.S. adults compared perceptions of the quality of physician care among fourteen racial and ethnic groups with those of whites. On each measure examined, at least five and as many as eleven subgroups perceived their care to be significantly worse than care for whites. In many instances, subgroups were at least fifteen percentage points more negative than whites. This was true for Central/South Americans, Chinese Americans, and Korean Americans on five of seven measures. Many of the differences remained after socioeconomic characteristics and language skills were controlled for.
[Bone complications of renal transplantation. How to identify and prevent them]

P Messa,A Aroldi,M Villa,E Rusconi

Abstract:Bone disease is a very frequent complication after renal transplantation (RTx). The main features of transplant bone disease include the osteopenic-osteoporotic syndrome, often complicated by fractures, avascular osteonecrosis of bones, bone pain syndrome and growth retardation in the children. The bone loss is greater during the first 12 months after RTx and can reach the osteoporotic range in above 40% of patients, with a fracture rate of 2-3% per year. The story of bone disease over the long pre-uremic and uremic period is one of the main causal factors. After RTx, glucocorticoid therapy seems to play the major causal role. Much more disputed is the role of the other immunosuppressive drugs, of persistent secondary hyperparathyroidism, and age. Hypophosphatemia and some genetic factors could also affect bone loss after RTx. Diabetic patients are particularly prone to develop bone disease after RTx. The main prophylactic interventions consist in the optimal control of hyperparathyroidism during the pre-transplant period, prescribing parathyroidectomy for autonomous hyperparathyroidism, not-responding to medical therapy. After RTx, both bisphosphonate and vitamin D metabolites, variably associated with calcium supplementation, have been demonstrated to have some beneficial effect on bone loss, at least in the first year after RTx. However, there are no data about the possible efficacy of these treatments on fracture rate.
THE BENEFITS OF POSITIVE FEEDBACK

E. Tytell

DOI: https://doi.org/10.1242/jeb.001016

IF: 3.308

2007-08-01

Journal of Experimental Biology

Abstract:![Figure][1] In both vertebrates and invertebrates, clusters of neurons fire rhythmically to generate the basic pattern for regular movements such as walking, swimming and gut peristalsis. These central pattern generators, or CPGs, need neither sensory input nor higher brain function to
Evaluation of parathyroidectomy for persistent hyperparathyroidism after kidney transplantation: a retrospective study

陆虎林,雷欣,黄洪锋,何永春,盛凯翔,陈少华,陈江华,张萍

DOI: https://doi.org/10.3760/cma.j.cn421203-20200214-00036

2020-01-01

Abstract:Objective:To explore the efficacy of parathyroidectomy(PTX)for persistent hyperparathyroidism(PHPT)after renal transplantation and examine the effect of PTX on renal allograft function.Methods:For this single-center retrospective study, 31 patients undergoing PTX for PHPT after renal transplantation from May 2010 to October 2018. The changes of serum calcium, serum phosphorus, alkaline phosphatase, parathyroid hormone(PTH), serum creatinine, and estimated glomerular filtration rate(eGFR)during peri-operative periods(1w, 1/3/6/12m)were compared. The operative successful rate(12 m)was calculated and postoperative complications were recorded. The definition of a successful operation was a normalization of blood calcium after PTX and/or a reduction of >50% in PTH as compared with pre-operation.Results:The serum calcium pre-PTX was(2.78±0.18)mmol/L and it decreased markedly to(2.19±0.34)mmol/L at 1 week post-operation( P<0.01). The serum phosphorus pre-PTX was(0.76±0.16)mmol/L and it dropped significantly to(0.97±0.26)mmol/L at 1 week post-operation( P<0.01). The pre-PTX level of PTH was(276.00±200.60)ng/L and it decreased significantly to(46.62±104.36)ng/L at 1 week post-operation( P<0.01). The pre-PTX level of alkaline phosphatase was(261.59±236.95)U/L and it declined significantly to(154.90±117.37)U/L at 3 months post-operation( P<0.01). No significant difference existed in postoperative serum creatinine or eGFR levels compared with baseline values. The operative successful rate was 90.3% at 12 months post-operation. The incidence rates of postoperative transient hypocalcemia, persistent hypoparathyroidism and hoarseness were 35.5%, 3.2% and 3.2% respectively. There was no persistent hypocalcemia, incision hemorrhage, incision infection or surgery-related death. Conclusions:PTX may quickly and effectively alleviate high calcium, low phosphorus, high PTH and high alkaline phosphatase after renal transplantation. Both effective and safe for PHPT after renal transplantation, PTX has no effect on renal allograft function.
Calcium phosphate deposition, tertiary hyperparathyroidism, and the long-term effect on kidney allografts

John X. Sun,Kristin E. Trone,Ranish K. Patel,Ali Oran,Nicole K. Andeen,David C. Woodland,Christopher R. Connelly,Olga S. Senashova,Maisie L. Shindo,Angelo M. de Mattos,James Y. Lim

DOI: https://doi.org/10.1016/j.surg.2024.05.052

IF: 4.348

2024-10-18

Surgery

Abstract:Background Tertiary hyperparathyroidism adversely affects kidney allografts, with calcium phosphate deposition hypothesized to be an underlying cause. We analyzed allograft biopsies to investigate risk factors for calcium phosphate deposition and understand its impact on allograft function. Methods We reviewed patients who underwent kidney transplantation from 2017 to 2019. Tertiary hyperparathyroidism was defined as an elevated parathyroid hormone and hypercalcemia beyond 3 months' posttransplant or being prescribed cinacalcet. Allograft failure was defined as needing dialysis posttransplantation or retransplantation beyond 3 months' posttransplant. Three- and 12-month allograft biopsies were reviewed for calcium phosphate deposition. The χ 2 , t -test, and multivariate regression were used for statistical analysis. Results Of 159 patients who underwent kidney transplantation, 59 (37.1%) were diagnosed with tertiary hyperparathyroidism. Longer preoperative dialysis vintage (odds ratio, 1.47; confidence interval, 1.22–1.80 P < .001) and preoperative cinacalcet usage (odds ratio, 18.4; confidence interval, 7.24–53.0 P < .001) were associated with tertiary hyperparathyroidism. In total, 36 of 59 (61%) patients with tertiary hyperparathyroidism had calcium phosphate deposition on 3- or 12-month kidney allograft biopsy compared with 23 of 100 (23%) patients without tertiary hyperparathyroidism ( P < .001). Tertiary hyperparathyroidism (odds ratio, 6.01; confidence interval, 2.91–13.0 P < .001) was associated with calcium phosphate deposition. Calcium phosphate deposition and tertiary hyperparathyroidism were not associated with worse glomerular filtration rate at 3 years' posttransplantation. Of those with data available at 3 years' posttransplantation, 21 of 49 (42.9%) patients remained on cinacalcet. There were 3 of 159 (2%) patients who had allograft failure, 2 of whom had both tertiary hyperparathyroidism and calcium phosphate deposition. Conclusion Preoperative variables associated with tertiary hyperparathyroidism included longer dialysis vintage and cinacalcet use. Tertiary hyperparathyroidism was the main risk factor for calcium phosphate deposition posttransplantation. In our population, calcium phosphate deposition and tertiary hyperparathyroidism were not significantly associated with lower glomerular filtration rate.

surgery
P1429EVALUATION OF PARATHYROIDECTOMY IN PERSISTENT HYPERARATHYROIDISM AFTER RENAL TRANSPLANTATION: A SINGLE-CENTER RETROSPECTIVE STUDY

Ping Zhang,Hulin Lu,Jianghua Chen

DOI: https://doi.org/10.1093/ndt/gfaa142.p1429

IF: 7.1857

2020-01-01

Nephrology Dialysis Transplantation

Abstract:Abstract Background and Aims To investigate the efficacy of parathyroidectomy (PTX) in the treatment of persistent hyperparathyroidism (PHPT) after renal transplantation and the effect of PTX on renal allograft function. Method This single-center retrospective study enrolled 31 patients who underwent PTX for the treatment of PHPT after renal transplantation in the Kidney Disease Center of the First Affiliated Hospital of Zhejiang University from May 2010 to Oct. 2018. The changes of serum calcium, serum phosphorus, alkaline phosphatase, parathyroid hormone(PTH), serum creatinine, and estimated glomerular filtration rate (eGFR) in the preoperative and postoperative periods (1w, 1m, 3m, 6m,12m) were compared. The operative successful rate (12 m) and postoperative complications were calculated. Results The serum calcium before PTX was (2.78±0.18) mmol/L, which decreased significantly to (2.19±0.34) mmol/L at 1 week postoperatively (P<0.01). The serum phosphorus before PTX was (0.76±0.16) mmol/L, which decreased significantly to (0.97±0.26) mmol/L at 1 week postoperatively (P<0.01). The PTH before PTX was (276.00±200.60) pg/mL, which decreased significantly to (46.62±104.36) pg/mL at 1 week postoperatively (P<0.01). The alkaline phosphatase before PTX was (261.59±236.95) U/L, which decreased significantly to (154.90±117.37) U/L at 3 months postoperatively (P<0.01). No significant difference was found in postoperative serum creatinine or eGFR levels compared with the baseline. The operative successful rate was 90.3% at 12 months postoperatively. The incidence rates of postoperative transient hypocalcemia, persistent hypoparathyroidism, and hoarseness were 35.5%, 3.2% and 3.2% respectively. No persistent hypocalcemia, incision hemorrhage, incision infection, or surgery-related death happened. Conclusion PTX can quickly and effectively alleviate high calcium, low phosphorus, high PTH and high alkaline phosphatase after renal transplantation. PTX is effective and safe in the treatment of PHPT after renal transplantation, and has no effect on renal allograft function.
Pre-Transplant Hyperparathyroidism and Graft or Patient Outcomes After Kidney Transplantation

Fernanda Guedes Rodrigues,Willemijn Y. Van Der Plas,Camilo German Sotomayor,Amarens Van Der Vaart,Daan Kremer,Robert A. Pol,Schelto Kruijff,Ita Pfeferman Heilberg,Stephan J. L. Bakker,TransplantLines Investigators,Martin H. De Borst,

DOI: https://doi.org/10.3389/ti.2024.11916

2024-02-07

Transplant International

Abstract:The impact of pre-transplant parathyroid hormone (PTH) levels on early or long-term kidney function after kidney transplantation is subject of debate. We assessed whether severe hyperparathyroidism is associated with delayed graft function (DGF), death-censored graft failure (DCGF), or all-cause mortality. In this single-center cohort study, we studied the relationship between PTH and other parameters related to bone and mineral metabolism, including serum alkaline phosphatase (ALP) at time of transplantation with the subsequent risk of DGF, DCGF and all-cause mortality using multivariable logistic and Cox regression analyses. In 1,576 kidney transplant recipients (51.6 ± 14.0 years, 57.3% male), severe hyperparathyroidism characterized by pre-transplant PTH ≥771 pg/mL (>9 times the upper limit) was present in 121 patients. During 5.2 [0.2–30.0] years follow-up, 278 (15.7%) patients developed DGF, 150 (9.9%) DCGF and 432 (28.6%) died. A higher pre-transplant PTH was not associated with DGF (HR 1.06 [0.90–1.25]), DCGF (HR 0.98 [0.87–1.13]), or all-cause mortality (HR 1.02 [0.93–1.11]). Results were consistent in sensitivity analyses. The same applied to other parameters related to bone and mineral metabolism, including ALP. Severe pre-transplant hyperparathyroidism was not associated with an increased risk of DGF, DCGF or all-cause mortality, not supporting the need of correction before kidney transplantation to improve graft or patient survival.

surgery,transplantation
Sympathetic reflex algodystrophy following kidney transplantation

D. Morel,L. Potaux,M.‐H. Lafage,P. Seniuta,V. de Precigout,P. Merville,J. Dehais,M. Aparicio

DOI: https://doi.org/10.1111/j.1399-0012.1989.tb00187.x

1989-08-01

Clinical Transplantation

Abstract:Between January 1985 and December 1987, 5 out of 109 cadaver‐kidney transplant recipients developed an algodystrophy involving knees and ankles. Pain hindering movements occurred during the 3rd month following transplantation. Radiographic findings demonstrated epiphysical demineralization and bone‐scanning revealed increased uptake of a radioisotope in the affected joints. Calcium and parathormone levels were either normal or subnormal. Recovery was always achieved after calcitonin or griseofulvin therapy. Different factors possibly promote the occurrence of this pathology: preexistent renal osteodystrophy with secondary hyperparathyroïdism and pelvis surgery might have played underlying but not determinant roles with regard to the 500 patients who underwent kidney transplantation before January 1985 and who never experienced algodystrophy. The only difference between the two groups of patients was the introduction of cyclosporin‐A therapy after 1985. We suggest that this drug might contribute to the onset of algodystrophy by its vasoconstrictive action on the peripheral vessels, by its neurotoxicity and/or by an increased bone‐remodelling effect.

surgery,transplantation

New Evolutionary Synthesis Tool for Modelling Young Star Clusters in Merging Galaxies

Isolated Idiopathic Transient Hyperphosphatasemia in an Adult Patient after Renal Transplantation: a Case Report.

Dynamics in the mixed microbial concourse.

[Aseptic osseous necrosis after renal transplantation]

Clinical Analysis of Persistent Hypercalcemia with Osteoporosis Caused by Tertiary Hyperparathyroidism after Kidney Transplantation

The effect of probucol on HDL-mediated sterol translocation and efflux from cells.

How to increase the population of a Phlebotomus perniciosus (Diptera: Psychodidae) colony: a new method.

Bone disease after renal transplantation

[Disturbances of the calcium-phosphorus metabolism and skeletal diseases following kidney transplantation]

Musculoskeletal complications after renal transplantation: pathogenesis and treatment

The decreased incidence of aseptic necrosis in renal transplant recipients--a case control study

Associated Factors of Osteoporosis and Vascular Calcification in Patients Awaiting Kidney Transplantation.

[Therapy recommendations for the use of intravenously applicable immunoglobulins].

Disparities in physician care: experiences and perceptions of a multi-ethnic America.

[Bone complications of renal transplantation. How to identify and prevent them]

THE BENEFITS OF POSITIVE FEEDBACK

Evaluation of parathyroidectomy for persistent hyperparathyroidism after kidney transplantation: a retrospective study

Calcium phosphate deposition, tertiary hyperparathyroidism, and the long-term effect on kidney allografts

P1429EVALUATION OF PARATHYROIDECTOMY IN PERSISTENT HYPERARATHYROIDISM AFTER RENAL TRANSPLANTATION: A SINGLE-CENTER RETROSPECTIVE STUDY

Pre-Transplant Hyperparathyroidism and Graft or Patient Outcomes After Kidney Transplantation

Sympathetic reflex algodystrophy following kidney transplantation